Association of Serum High Molecular Weight Adeponectin and Blood Pressure among Non-Diabetic Community-Dwelling Men

REFERENCES

• Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, BOyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003;46:459–469.
   PubMed Web of Science ®Google Scholar
• Lam KS, Yum A. Adiponectin. Protection of the endothelium. Cur Diab Rep 2005;5: 254–259.
   PubMedGoogle Scholar
• Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, Yamaguchi H, Ohnuma H, Igarashi M, Tominaga M, Kato T. Funagata study: Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study. Diabetes Care 2003;26:2015–2020.
   PubMed Web of Science ®Google Scholar
• Chow WS, Cheung BM, Tso AW, Xu A, Wat NM, Fong CH, Ong LH, Tam S, Tan KC, Janus ED, Lam TH, Lam KS. Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study. Hypertension 2007;49:1455–1461.
   PubMed Web of Science ®Google Scholar
• Seino Y, Hirose H, Saito I, Itoh H. High-molecular-weight adiponectin is a predictor of progression to metabolic syndrome: a population-based 6-year follow-up study in Japanese men. Metabolism 2009;58:355–360.
   PubMed Web of Science ®Google Scholar
• Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004;291:1730–1737.
   PubMed Web of Science ®Google Scholar
• Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, hara K, Hada Y, Vasseur F, Froguel P, Kimura S, Nagai R, Kadowaki T. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 2003;278,40352–40363.
   PubMed Web of Science ®Google Scholar
• Hada Y, Yamauchi T, Waki H, Tsuchida A, Hara K, Yago H, Miyazaki O, Ebinuma H, Kadowaki T. Selective purification and characterization of adiponectin multimer species from human plasma. Biochem Biophys Res Commun 2007;356:487–493.
   PubMed Web of Science ®Google Scholar
• Qureshi AI, Suri MF, Kirmani JF, Divani AA, Mohammad Y. Is prehypertension a risk factor for cardiovascular diseases? Stroke 2005;36,1859–1863.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Yamamoto T, Okamura T, Kadowaki T, Hayakawa T, Kita Y, Saitoh S, Okayama A, Ueshima H. The NIPPON DATA 80 Research Group: Combined cardiovascular risk factors and outcome: NIPPON DATA80, 1980-1994. Circ J 2006;70:960–964.
   PubMed Web of Science ®Google Scholar
• Baumann M, von Eynatten M, Dan L, Richart T, Kouznetsova T, Heemann U, Staessen JA.. Altered molecular weight forms of adiponectin in hypertension. J Clin Hypertens 2009;11:11–16.
   Web of Science ®Google Scholar
• Seino Y, Hirose H, Saito I, Itoh H. High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men. Metabolism 2007;56:1493–1499.
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee: The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206–1252.
   PubMed Web of Science ®Google Scholar
• Nakano Y, Tajima S, Yoshimi A, Akiyama H, Tsushima M, Tanioka T, Negoro T, Tomita M, Tobe T. A novel enzyme-linked immunosorbent assay specific for high-molecular-weight adiponectin. J Lipid Res 2006;47:1572–1582.
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502.
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–419.
   PubMed Web of Science ®Google Scholar
• Tabara Y, Osawa H, Kawamoto R, Tachibana-limori R, Yamamoto M, Nakura J, Miki T, Makino H, Kohara K. Reduced high-molecular-weight adiponectin and elevated high-sensitivity C-reactive protein are synergistic risk factors for metabolic syndrome in a large-scale middle-aged to elderly population: the Shimanami Health Promoting Program Study. J Clin Endocrinol Metab 2007;93:715–722.
   PubMed Web of Science ®Google Scholar
• Lara-Castro C, Luo N, Wallace P, Klein RL, Garvey WT. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 2006;55:249–259.
   PubMed Web of Science ®Google Scholar
• Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ibinuma H, Imai Y, Nagai R, Kadowaki T. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 2006;29:1357–1362.
   PubMed Web of Science ®Google Scholar
• Liu Y, Retnakaran R, Hanley A, Tungtrongchitr R, Shaw C, Sweeney G. Total and high molecular weight but not trimeric or hexameric forms of adiponectin correlate with markers of the metabolic syndrome and liver injury in Thai subjects. J Clin Endocrinol Metab 2007;92:4313–4318.
   PubMed Web of Science ®Google Scholar
• Tsai PS, Ke TL, Huang CJ, Chen PL, Wang SY, Shyu YK. Prevalence and determinants of prehypertension status in the Taiwanese general population. J Hypertens 2005;23:1355–1360.
   PubMed Web of Science ®Google Scholar
• Greenlund KJ, Croft JB, Mensah GA. Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999–2000. Arch Intern Med 2004;164:2113–2118.
   PubMed Web of Science ®Google Scholar
• Shankar A, Marshall S, Li J. The association between plasma adiponectin level and hypertension. Acta Cardiol 2008;63:160–165.
   PubMed Web of Science ®Google Scholar
• Li HY, Chiu YF, Hwu CM, Sheu WH, Hung YJ, Fujimoto W, Quertermous T, Curb JD, Tai TY, Chuang LM. The negative correlation between plasma adiponectin and blood pressure depends on obesity: a family-based association study in SAPPHIRe. Am J Hypertens 2008;21:471–476.
   PubMed Web of Science ®Google Scholar
• Bener A, Zirie M, Musallam M, Khader YS, Al-Hamaq AO. Prevalence of Metabolic Syndrome According to Adult Treatment Panel III and International Diabetes Federation Criteria: A Population-Based Study. Metab Syndr Relat Disord 2009; 7:221–229.
   Google Scholar
• Kawamoto R, Kohara K, Tabara Y, Abe M, Kusunoki T, Miki T. Insulin Resistance and Prevalence of Prehypertension among Community-Dwelling Persons. J Atheroscler Thromb 2010;17:148–155.
   PubMed Web of Science ®Google Scholar
• Schelbert HR. Coronary circulatory function abnormalities in insulin resistance: insights from positron emission tomography. J Am Coll Cardiol 2009;53:S3–S8.
   PubMed Web of Science ®Google Scholar
• Flaa A, Aksnes TA, Kjeldsen SE, Eide I, Rostrup M. Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study. Metabolism 2008:57:1422–1427.
   PubMed Web of Science ®Google Scholar
• Grattagliano I, Palmieri VO, Portincasa P, Moschetta A, Palasciano G. Oxidative stress-induced risk factors associated with metabolic syndrome: a unifying hypothesis. J Nutr Biochem 2008;19:491–504.
   PubMed Web of Science ®Google Scholar
• Grunfeld B, Gimenez M, Balzaretti M, Rabinovich L, Romo M, Simsolo R. Insulin Effect on Renal Sodium Reabsorption in Adolescent Offspring of Essential Hypertensive Parents. Hypertension 1995;26:1089–1092.
   PubMed Web of Science ®Google Scholar
• Lastra-Lastra G, Sowers JR, Restrepo-Erazo K, Manrique-Acevedo C, Lastra-Gonzalez G. Role of aldosterone and angiotensin II in insulin resistance: an update. Clin Endocrinol 2008;71:1–6.
   PubMed Web of Science ®Google Scholar
• Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K, Fu Y, Motone M, Yamamoto K, Matsuo A, Ohashi K, Kihara S, Funahashi T, Rakugi H, Matsuzawa Y, Ogihara T. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 2004;43:1318–1323.
   PubMed Web of Science ®Google Scholar
• Hattori Y, Suzuki M, Hattori S, Kasai K. Globular adiponectin upregulates nitric oxide production in vascular endothelial cells. Diabetologia 2003;46:1543–1549.
   PubMed Web of Science ®Google Scholar
• Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 2003;278:45021–45026.
   PubMed Web of Science ®Google Scholar
• Motoshima H, Wu X, Mahadev K, Goldstein BJ. Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL. Biochem. Biophys. Res Commun 2004;315:264–271.
   Google Scholar
• Ouedraogo R, Wu X, Xu SQ, Fuchsel L, Motoshima H, Mahadev K, Hough K, Scalia R, Goldstein BJ. Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway. Diabetes 2006;55:1840–1846.
   PubMed Web of Science ®Google Scholar
• Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F. Chronic Kidney Disease Epidemiology Collaboration: Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in the renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006;145: 247–254.
   PubMed Web of Science ®Google Scholar